Stewart Little, MD
Plastic and Reconstructive Surgery · Chattanooga, TNNPI 1558583021
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Lilly USA, LLC at 40.1% of the total. Reporting peaked in 2019 at $563 and has fallen 89.9% since, to $57 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in TN, where the typical reported total is $1,929.
Across 71 payments — averaging $22.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$637
- Sanofi$234
- Regeneron Healthcare Solutions, Inc.$159
- Merz North America, Inc.$134
- Johnson & Johnson$109
- Genentech USA, Inc.$101
- plus $215 from 8 others
What the payments were for
- Food & beverage$1,590100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 35 | $637 |
| Sanofi | 3 | $234 |
| Regeneron Healthcare Solutions, Inc. | 7 | $159 |
| Merz North America, Inc. | 2 | $134 |
| Johnson & Johnson | 7 | $109 |
| Genentech USA, Inc. | 6 | $101 |
| AbbVie | 3 | $68 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $30 |
| Revance Therapeutics, Inc. | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| UCB, Inc. | 1 | $17 |
| VYNE Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$106
How this compares
$1,590 in reported general payments places this provider in the 40th percentile of 77 plastic and reconstructive surgery providers in Tennessee.
See all plastic and reconstructive surgery providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 15 | $82 |
| Mupirocin | 13 | $79 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Chattanooga
- Mark BrzezienskiChattanooga$32K
- Jason RehmChattanooga$10K
- Todd ThurstonChattanooga$2K
- Jimmy WaldropChattanooga$2K
- William HickersonMemphis$833K
- Daniel HatefNashville$673K
- Earl LettMount Juliet$29K
- Robert WallaceMemphis$21K
- Lois WagstromNashville$19K
- Jordi Puente EspelNashville$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.